Trial intelligence / Profile preview

Ethinylestradiol + dienogest add-on to inpatient psychotherapy in adult females with anorexia nervosa

2015-004184-36Phase 2Terminated

Sponsor
Universitätsklinikum Erlangen
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in anorexia nervosa (AN) comparing Ethinylestradiol + dienogest plus in-house psychotherapy with Placebo plus in-house psychotherapy (2 arms). Primary endpoint: Change in neuropsychological performance. Started Dec 2015; status: terminated.

02

Drugs

ethinyl estradioldienogest
03

Conditions

anorexia nervosa (AN)

Beyond the preview

Go deeper on 2015-004184-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004184-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call